Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.38.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.14 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.359NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.8 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.39.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.82 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.466.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.213NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.56 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.91.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
XMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.8.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EC.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XLNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.87 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.11.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.10.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used